EGFR and non-small cell lung carcinoma: Our database analysis revealed that EGFR/TP53/CUL3 triple mutations account for only 0.4% of EGFR‐mutant NSCLC cases and seemed associated with a lower OS than EGFR/TP53 double mutations, although not significantly so (possibly owing to the small sample size).